Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma-Reference-Cited by-同舟云学术

Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma

Published:2018-11-01 Issue:11 Volume:136 Page:1236
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Sagiv Oded¹,Thakar Sudip D.¹,Kandl Thomas J.¹,Ford Joshua¹,Sniegowski Matthew C.¹,Hwu Wen-Jen²,Esmaeli Bita¹

Affiliation:

1. Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston

2. Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Reference17 articles.

1. Management of conjunctival malignant melanoma: a review and update.;Wong;Expert Rev Ophthalmol,2014

2. Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis).;Esmaeli;Trans Am Ophthalmol Soc,2012

3. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.;Shields;Trans Am Ophthalmol Soc,2000

4. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma.;Schadendorf;J Clin Oncol,2015

5. FDA approval of nivolumab for the first-line treatment of patients with BRAFV600 wild-type unresectable or metastatic melanoma.;Beaver;Clin Cancer Res,2017

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Periocular granulomatous inflammatory lesions mimicking conjunctival melanoma recurrence in the setting of systemic nivolumab treatment;American Journal of Ophthalmology Case Reports;2024-12

2. Conjunctival Melanoma: A Clinical Review and Update;Cancers;2024-09-10

3. Primary Treatment of Eyelid Conjunctival Melanoma with Immunotherapy: A Case Report;Ophthalmic Plastic & Reconstructive Surgery;2024-09-06

4. Advances in conjunctival melanoma: clinical features, diagnostic modalities, staging, genetic markers, and management;CAN J OPHTHALMOL;2024

5. Immune Checkpoint Inhibitor Therapy for Periocular Merkel Cell Carcinoma;Ophthalmology;2024-08